LGALS8 and lung carcinoma: Also, the presence of Gal-8 in lung tumor cells and the absence or low levels of it in normal lung tissue allows the use of monoclonal antibodies (Po66) for the treatment of lung cancer, in the beginning, this antibody was specifically able to connect to Gal-8 and was used to detect human SCC by immunoscintigraphy (8,9).